A Cirugeda
Overview
Explore the profile of A Cirugeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
123
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Del Peso G, Jimenez-Heffernan J, Bajo M, Aroeira L, Aguilera A, Fernandez-Perpen A, et al.
Kidney Int Suppl
. 2008 May;
(108):S26-33.
PMID: 18379544
Ultrafiltration (UF) failure is a consequence of long-term peritoneal dialysis (PD). Fibrosis, angiogenesis, and vasculopathy are causes of this functional disorder after 3-8 years on PD. Epithelial-to-mesenchymal transition (EMT) of...
2.
Barril G, Cigarran S, Friera A, Gallego C, Perpen A, Cirugeda A, et al.
J Vasc Access
. 2007 Jul;
1(2):70-2.
PMID: 17638228
One of the last options, when the other possibilities of vascular access present malfunction, is the insertion of a permanent catheter in a central vein, preferentially internal jugular vein. This...
3.
Jimenez-Heffernan J, Cirugeda A, Bajo M, Del Peso G, Perez-Lozano M, Perna C, et al.
Int J Artif Organs
. 2005 Mar;
28(2):105-11.
PMID: 15770598
Objective: To evaluate the utility of peritoneal pathologic samples, unrelated to peritoneal dialysis (PD) treatment, for the study of peritoneal fibrosis and inflammation. Methods: Comparative morphologic and immunohistochemical study of...
4.
Aguilera A, Aroeira L, Ramirez-Huesca M, Perez-Lozano M, Cirugeda A, Bajo M, et al.
Int J Artif Organs
. 2005 Mar;
28(2):164-9.
PMID: 15770593
The preservation of the peritoneal membrane is crucial for long-term survival in peritoneal dialysis. Epithelial-to-mesenchymal transition (EMT) is a process demonstrated in mesothelial cells (MC), responsible for negative peritoneal changes...
5.
Sansone G, Cirugeda A, Bajo M, Del Peso G, Sanchez Tomero J, Alegre L, et al.
Nefrologia
. 2005 Jan;
24(5):410-45.
PMID: 15648901
No abstract available.
6.
Selgas R, Bajo M, Aguilera A, Sanchez-Tomero J, Cirugeda A, Del Peso G, et al.
Nefrologia
. 2004 Apr;
24(1):34-9.
PMID: 15083955
No abstract available.
7.
Selgas R, Cirugeda A, Sansone G
Nefrologia
. 2003 Oct;
23(4):298-9.
PMID: 14558328
No abstract available.
8.
Selgas R, Bajo M, Cirugeda A, Del Peso G, Aguilera A, Gil F, et al.
Nefrologia
. 2003 Aug;
23 Suppl 3:38-43.
PMID: 12901191
No abstract available.
9.
Castro M, Bajo M, Del Peso G, Larrocha C, Castro M, Sanchez-Tomero J, et al.
Nefrologia
. 2003 Aug;
23(3):243-51.
PMID: 12891939
Unlabelled: Mesothelial cells (MC) are the first peritoneal membrane barrier in contact with dialysate. The aim of this study was to analyze the in vitro capacity of different pharmacological agents...
10.
Selgas R, Cirugeda A, Fernandez-Perpen A, Sanchez-Tomero J, Barril G, Alvarez V, et al.
Int Urol Nephrol
. 2002 Jul;
33(2):259-64.
PMID: 12092638
This meta-analysis had the aim of studying the available studies on comparison between Hemodialysis and Peritoneal Dialysis in the elderly. The final objective was to reach, if possible, evidence for...